IT1274592B - Composizione farmaceutica per la terapia tumorale contenente xenoantigeni - Google Patents

Composizione farmaceutica per la terapia tumorale contenente xenoantigeni

Info

Publication number
IT1274592B
IT1274592B ITMI941713A ITMI941713A IT1274592B IT 1274592 B IT1274592 B IT 1274592B IT MI941713 A ITMI941713 A IT MI941713A IT MI941713 A ITMI941713 A IT MI941713A IT 1274592 B IT1274592 B IT 1274592B
Authority
IT
Italy
Prior art keywords
xenoantigens
pharmaceutical composition
cancer therapy
therapy containing
hclo41n
Prior art date
Application number
ITMI941713A
Other languages
English (en)
Inventor
Angela Turiano
Original Assignee
Angela Turiano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angela Turiano filed Critical Angela Turiano
Publication of ITMI941713A0 publication Critical patent/ITMI941713A0/it
Priority to ITMI941713A priority Critical patent/IT1274592B/it
Priority to ES95904529T priority patent/ES2285702T3/es
Priority to PCT/EP1994/004290 priority patent/WO1996004005A1/en
Priority to DK95904529T priority patent/DK0773789T3/da
Priority to AT95904529T priority patent/ATE357926T1/de
Priority to US08/817,595 priority patent/US20030045453A1/en
Priority to PT95904529T priority patent/PT773789E/pt
Priority to DE69434946T priority patent/DE69434946T2/de
Priority to EP95904529A priority patent/EP0773789B1/en
Publication of ITMI941713A1 publication Critical patent/ITMI941713A1/it
Application granted granted Critical
Publication of IT1274592B publication Critical patent/IT1274592B/it
Priority to US11/107,782 priority patent/US20050238653A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

si descrivono xenoantigeni scelti fra le molecole di istocompatibilità ottenibili per estrazione da omogenati di tessuti o cellule con detergente Nonidet P40 o con acido HCLO41N, per l'uso come medicamento per la stimolazione del sistema immunitario dell'uomo e dei mammiferi, ed in particolare per la terapia tumorale.(fig. 2).
ITMI941713A 1994-08-05 1994-08-05 Composizione farmaceutica per la terapia tumorale contenente xenoantigeni IT1274592B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI941713A IT1274592B (it) 1994-08-05 1994-08-05 Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
AT95904529T ATE357926T1 (de) 1994-08-05 1994-12-22 Verwendung von mhc-xenoantigenes zur herstellung eines arzneimittels für eine therapeutische behandlung von krebs
PCT/EP1994/004290 WO1996004005A1 (en) 1994-08-05 1994-12-22 Pharmaceutical compositions containing extracted mhc molecules, for stimulation of the immune system
DK95904529T DK0773789T3 (da) 1994-08-05 1994-12-22 Anvendelse af MHC-xenoantigener til fremstilling af et medikament til cancerbehandling
ES95904529T ES2285702T3 (es) 1994-08-05 1994-12-22 Uso de xenoantigeno mhc en la fabricacion de medicamento para el tratamiento de cancer.
US08/817,595 US20030045453A1 (en) 1994-08-05 1994-12-22 Pharmaceutical composition for stimulation of the immune system
PT95904529T PT773789E (pt) 1994-08-05 1994-12-22 Composições farmacêuticas contendo moléculas de mhc extraidas para estimular o sistema imunitário
DE69434946T DE69434946T2 (de) 1994-08-05 1994-12-22 Verwendung von Haupthistokompatibilitätskomplex (MHC)-Xenoantigenen bei der Herstellung eines Medikamentes für eine therapeutische Behandlung von Krebs
EP95904529A EP0773789B1 (en) 1994-08-05 1994-12-22 Use of MHC xenoantigen in the manufacture of a medicament for the treatment of cancer
US11/107,782 US20050238653A1 (en) 1994-08-05 2005-04-18 Pharmaceutical compositions containing extracted MHC molecules, for stimulation of the immune system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941713A IT1274592B (it) 1994-08-05 1994-08-05 Composizione farmaceutica per la terapia tumorale contenente xenoantigeni

Publications (3)

Publication Number Publication Date
ITMI941713A0 ITMI941713A0 (it) 1994-08-05
ITMI941713A1 ITMI941713A1 (it) 1996-02-05
IT1274592B true IT1274592B (it) 1997-07-18

Family

ID=11369459

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI941713A IT1274592B (it) 1994-08-05 1994-08-05 Composizione farmaceutica per la terapia tumorale contenente xenoantigeni

Country Status (9)

Country Link
US (2) US20030045453A1 (it)
EP (1) EP0773789B1 (it)
AT (1) ATE357926T1 (it)
DE (1) DE69434946T2 (it)
DK (1) DK0773789T3 (it)
ES (1) ES2285702T3 (it)
IT (1) IT1274592B (it)
PT (1) PT773789E (it)
WO (1) WO1996004005A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2172322C1 (ru) 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Аллофероны-иммуномодулирующие пептиды

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201023D0 (en) * 1992-01-17 1992-03-11 Medical Res Council Vaccines
JPH05246889A (ja) * 1992-03-05 1993-09-24 Seitai Chiyousetsu Kenkyusho:Kk 制癌方法および制癌剤
EP0569678A3 (de) * 1992-03-13 1994-10-26 Yeda Res & Dev Mit MHC-Genen doppelt transfizierte Zellen als Impfstoffe zur Immunoprevention von Tumormetastasen.
GB9214871D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Vaccines
JPH08509204A (ja) * 1992-12-17 1996-10-01 スリラム，サブラマニアム 自己免疫疾患の治療のためのｍｈｃクラス▲ｉｉ▼分子のペプチドを用いた予防接種

Also Published As

Publication number Publication date
DE69434946T2 (de) 2007-12-06
DK0773789T3 (da) 2007-05-29
ITMI941713A1 (it) 1996-02-05
WO1996004005A1 (en) 1996-02-15
EP0773789B1 (en) 2007-03-28
ITMI941713A0 (it) 1994-08-05
ATE357926T1 (de) 2007-04-15
PT773789E (pt) 2007-04-30
EP0773789A1 (en) 1997-05-21
US20050238653A1 (en) 2005-10-27
ES2285702T3 (es) 2007-11-16
DE69434946D1 (de) 2007-05-10
US20030045453A1 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
IT8322630A0 (it) Preparato di medicamento per migliorare i sintomi del cancro.
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
IT1291822B1 (it) Sistema per la defibrillazione elettrica cardiaca impiantabile con attenuazione del dolore derivante dallo shock elettrico mediante
IT8027029A0 (it) Complessi platino-diamminici e formulazioni farmaceutiche per il trattamento del cancro che licontengono.
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
ATE197903T1 (de) Peptid-kohlenwasserstoff konjugate, welche t-zell immunität bewirken
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
IL146125A0 (en) Novel quinones as disease therapies
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
DK360188D0 (da) Laegemiddelafgivelsesorgan
DK528988D0 (da) Laegemiddelafgivelsessystem
EP0305117A3 (en) 2',3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections
TW261615B (it)
IT8720181A0 (it) Composizioni farmaceutiche contenenti alcoli superiori per il trattamento di patologie della prostata.
ZA943553B (en) Tri(platinum) complexes
FI883381A7 (fi) Terapeutiska medel.
IT8920898A0 (it) Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica.
PL315127A1 (en) Deuterised biologically active substances for percutaneous administration
IT1274592B (it) Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
IT1255241B (it) Derivato di acido biliare e suo uso in terapia
UA27099C2 (uk) Склад для протипухлиhhої терапії у формі розчиhу, спосіб його одержаhhя та лікарський засіб для протипухлиhhої терапії
MD457G2 (ro) Derivaţi noi de naftiridină, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizarea lor ca medicamente de antireproducere

Legal Events

Date Code Title Description
0001 Granted